Valuation check: DRTSW's ROE is -210.13%, below the sector sector average of -5.68%.
Get informed when a big investor buys or sells
+ Follow-210.13%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Alpha Tau Medical Ltd - Warrants (07/03/2027) (DRTSW) currently reports a ROE of -210.13%. That is below the sector sector average of -5.68%. Use the charts on this page to explore Alpha Tau Medical Ltd - Warrants (07/03/2027)'s ROE history and peer comparisons.
Alpha Tau Medical Ltd - Warrants (07/03/2027)'s ROE of -210.13% is lower than the its sector sector average of -5.68%. That is roughly 3597.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but Alpha Tau Medical Ltd - Warrants (07/03/2027)'s current -210.13% should be judged against industry norms (sector average: -5.68%) and against DRTSW's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of -210.13%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is -5.68%. From there, open related valuation or income-statement pages for Alpha Tau Medical Ltd - Warrants (07/03/2027), and consider following DRTSW for alerts when major investors trade the stock.